Filter
1155
Filtered Results: 1155
Text search:
infect
drug
use
Featured
Recommendations
124
New Publications
215
Language
Document type
No document type
610
Studies & Reports
228
Guidelines
201
Manuals
37
Strategic & Response Plan
25
Fact sheets
25
Training Material
15
Infographics
6
Situation Updates
5
Brochures
2
Resource Platforms
1
Countries / Regions
India
42
Western and Central Europe
31
South Africa
29
Global
26
Latin America and the Carribbean
20
Uganda
19
Eastern Europe
19
Russia
19
Ethiopia
18
Africa
17
Tanzania
16
Ukraine
16
Kenya
15
Nigeria
14
Brazil
14
Malawi
13
Zambia
12
Germany
11
Philippines
10
Namibia
10
Senegal
9
Nepal
9
Colombia
9
Asia
9
Ghana
8
Mozambique
8
Sierra Leone
7
Liberia
7
Burkina Faso
6
Rwanda
6
West and Central Africa
6
Congo, Democratic Republic of
5
Cameroon
5
Cambodia
5
Argentina
5
Botswana
5
Myanmar / Burma
5
East and Southern Africa
5
Middle East and North Africa
5
South–East Asia Region
5
Eastern Europe and Central Asia
5
Zimbabwe
4
South Sudan
4
Bangladesh
4
Peru
4
Venezuela
4
Mali
3
USA
3
Syria
3
Thailand
3
Benin
3
Lesotho
3
Yemen
3
Albania
3
Armenia
3
Vietnam
3
Guinea
2
Guinea-Bissau
2
Pakistan
2
Jordan
2
Turkey
2
China
2
Indonesia
2
Sudan
2
Eswatini/ Swaziland
2
North Macedonia
2
Angola
2
Mexico
2
Paraguay
2
Southern Africa
2
Tajikistan
2
Uruguay
2
France
2
Spain
2
Côte d’Ivoire / Ivory Coast
1
Niger
1
Haiti
1
Egypt
1
Chad
1
Gambia
1
Switzerland
1
Serbia
1
Honduras
1
Ecuador
1
El Salvador
1
Bolivia
1
Libya
1
Guatemala
1
Madagascar
1
Nicaragua
1
Laos
1
Congo-Brazzaville
1
Estonia
1
Romania
1
Georgia
1
North America
1
Belgium
1
United Kingdom
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
295
Clinical Guidelines
152
Public Health
43
Women & Child Health
29
Pharmacy & Technologies
17
Capacity Building
14
Key Resources
11
Toolboxes
HIV
231
TB
212
AMR
106
COVID-19
105
NTDs
71
Rapid Response
30
Ebola
27
Refugee
23
Planetary Health
21
Caregiver
16
Pharmacy
15
Polio
9
Mental Health
9
Global Health Education
8
Cholera
7
NCDs
6
Conflict
5
Zika
5
Health Financing Toolbox
5
Specific Hazards
3
Disability
2
Natural Hazards
1
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to S...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly ...d to cure Plasmodium vivax malaria, as well as from other medicines and substances.
Antimicrobials are widely used in food animal production, and use is rapidly increasing.
In an era of growing demand for animal products, there is an increasing trend towards the industrial product...
braz j infect dis. 2014;18(5):491–495
http://dx.doi.org/10.1016/j.bjid.2014.02.004
1413-8670/© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Guidance statement
Recommendations on contraceptive methods used by
women at high risk of HIV
INTRODUCTION: Health service use among the public can decline during outbreaks and had been predicted among low and middle-income countries during the COVID-19 pandemic. In March 2020, the government of the Democratic Republic of the Congo (DRC) sta...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on conside...
J Epidemiol Infect Dis 1(1): 00003.n DOI: 10.15406/jeid.2017.01.00003
Published: September 14, 2017
The document describes the use of strategic information at various stages of the response in the context of strengthening broader health information systems. Strategic information can be defined as data collected at all service delivery and administ...
The framework is to be used as a reference guide, applied according to local priorities and needs, and targeted at academic institutions, educators, accreditation bodies, regulatory agencies and other use<...
Managing possible serious bacterial infection in young infants when referral is not feasible
recommended
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenge...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not t...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent C...
This diagnostic and treatment manual is designed for use by medical professionals involved in curative care at the dispensary and hospital levels. We have tried to respond in the simplest and most practical way possible to the questions and problems...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of...
